What is the recommended method to switch from sertraline (Zoloft) to brexpiprazole (Rexulti)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Switching from Sertraline (Zoloft) to Brexpiprazole (Rexulti)

You should not directly switch from sertraline to brexpiprazole as monotherapy, as brexpiprazole is not indicated as a standalone treatment for depression. Brexpiprazole (Rexulti) is FDA-approved only as adjunctive therapy to antidepressants for major depressive disorder (MDD), not as monotherapy 1.

The Correct Approach: Adjunctive Therapy

Add brexpiprazole to your existing sertraline regimen rather than switching. This is the evidence-based and FDA-approved strategy 1.

Dosing Protocol for Adding Brexpiprazole to Sertraline

When adding brexpiprazole to sertraline 1:

  • Days 1-4: Start brexpiprazole 0.5-1 mg once daily
  • Days 5-7: Increase to 1 mg once daily
  • Day 8 onward: Increase to target dose of 2 mg once daily
  • Maximum dose: 3 mg once daily if needed

Critical Drug Interaction Consideration

Sertraline is a CYP2D6 inhibitor, which increases brexpiprazole levels 2, 1. However, the FDA label specifically notes that in MDD clinical trials, dosage adjustments were NOT made for strong CYP2D6 inhibitors like sertraline, and these considerations are already factored into the general dosing recommendations 1. Therefore, you can use standard brexpiprazole dosing (2-3 mg/day) without adjustment when combining with sertraline 1.

Evidence Supporting Combination Therapy

Recent high-quality evidence demonstrates that brexpiprazole combined with sertraline is significantly more effective than sertraline alone for treatment-resistant symptoms 3. In a 2025 randomized controlled trial, the brexpiprazole + sertraline combination showed:

  • Greater improvement in depression scores (CAPS-5 LS mean difference: -5.08 points, P=0.011) 3
  • Efficacy in patients with both minimal and partial response to antidepressants 4
  • Benefits across all stages of disease course 5

Monitoring Requirements

Begin monitoring within 1-2 weeks of adding brexpiprazole 6, 7:

  • Assess for akathisia (occurs in 13.3% with brexpiprazole) 3
  • Monitor weight (weight gain occurs in 12.5% with combination) 3
  • Watch for somnolence (10% incidence) 3
  • Evaluate for extrapyramidal symptoms, though risk is lower with brexpiprazole than typical antipsychotics 1

If You Must Discontinue Sertraline

If there is a compelling reason to stop sertraline entirely (severe adverse effects, drug interactions, patient preference), you cannot simply replace it with brexpiprazole monotherapy as this is not an FDA-approved indication 1.

Instead, you would need to:

  1. Taper sertraline slowly over 10-14 days to avoid discontinuation syndrome (dizziness, nausea, paresthesias, anxiety) 2, 8, 2
  2. Switch to a different antidepressant using cross-tapering or direct switch methods 9, 10
  3. Then add brexpiprazole as adjunctive therapy to the new antidepressant if needed

Common Pitfall to Avoid

Do not attempt to use brexpiprazole as monotherapy for depression. While it showed efficacy in combination with sertraline for PTSD 3, brexpiprazole monotherapy did NOT separate from placebo in that same trial 3. The medication requires an antidepressant backbone to be effective for mood disorders.

References

Guideline

clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders.

Journal of the American Academy of Child and Adolescent Psychiatry, 2020

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.